http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113777324-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_48f36a2ea5aa45dcb5ea60f62470781a |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-325 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-7155 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54326 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 |
filingDate | 2021-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55947c2046ccfaadbdba10af0e79bb7f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_effd67587252236fe6099c669c805610 |
publicationDate | 2021-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-113777324-A |
titleOfInvention | Growth stimulation expression factor 2 instant detection kit, preparation method and application thereof |
abstract | The invention relates to a growth stimulation expression factor 2 instant detection kit, a preparation method and application thereof, wherein the instant detection kit comprises alkaline phosphatase marked anti-growth stimulation expression factor 2 antibody working solution, hydroxyl magnetic bead coated anti-growth stimulation expression factor 2 antibody working solution, luminescent substrate working solution and working cleaning solution; the luminescent substrate working solution comprises a substrate solvent and 0.5 percent of bovine serum albumin; the substrate solvent comprises the following components: diethanolamine 40%, 1M sodium hydroxide solution 30%, 0.1M magnesium chloride solution 10%, 0.25% Proclin300 solution 10%, 0.5% gemini surfactant solution 5% and AMPPD 5%. The gemini surfactant solution has the advantages of more compact surface arrangement, lower surface energy, higher surface activity, capability of improving the solubility of AMPPD in distilled water, promotion of chemiluminescence reaction efficiency and lower critical micelle concentration. Bovine serum albumin and a gemini surfactant are matched for use, so that the luminosity can be obviously enhanced, and the detection sensitivity is further obviously enhanced. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115078739-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115078739-B |
priorityDate | 2021-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 95.